Nebivolol 5 mg + HCTZ 12.5 mg Tablet Exporter from India

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Nebivolol 5 mg + Hydrochlorothiazide (HCTZ) 12.5 mg Tablets combine a selective beta-blocker with a thiazide diuretic to provide effective management of hypertension. The formulation works by lowering heart rate and reducing excess fluid retention, helping maintain healthy blood pressure levels.

This combination therapy is widely used in patients who require additional blood pressure control beyond single-drug treatment. The complementary action of Nebivolol and Hydrochlorothiazide supports improved cardiovascular outcomes and long-term hypertension management. Genliva Wellness LLP supplies high-quality Nebivolol 5 mg + HCTZ 12.5 mg Tablets for International Healthcare Markets.

Produced in compliance with stringent quality standards, the formulation offers reliable efficacy and patient safety. As a dependable Nebivolol + HCTZ Tablet Global Supplier and Nebivolol Hydrochlorothiazide Tablet Manufacturer in India, we serve pharmaceutical companies and distributors worldwide.

Nebivolol 5 mg + HCTZ 12.5 mg Tablets are formulated to provide comprehensive blood pressure control.

Combination of Nebivolol and Hydrochlorothiazide
Beta-blocker and diuretic therapy
Supports effective hypertension management
Helps reduce fluid retention
Suitable for long-term treatment
Consistent therapeutic performance

Nebivolol 5 mg + HCTZ 12.5 mg Tablets are indicated for the treatment of hypertension.

Essential hypertension
Uncontrolled high blood pressure
Long-term cardiovascular management
Combination antihypertensive therapy
Blood pressure stabilization

The combination helps achieve effective blood pressure control through complementary therapeutic actions.

Dual-action antihypertensive effect
Helps reduce blood pressure effectively
Supports cardiovascular health
Assists in reducing fluid overload
Suitable for long-term use
Improves hypertension treatment outcomes